| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/1991 | EP0412115A1 Hybrid peptides and methods of their use |
| 02/13/1991 | EP0412105A1 Stem cell inhibitors |
| 02/13/1991 | CN1049166A Substitution analogues of magainin peptides |
| 02/13/1991 | CN1049165A N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe and phenethylamine derivatives |
| 02/13/1991 | CN1049164A Aminooligohydroxy derivatives for inhibiting renin and process for preparing same |
| 02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
| 02/12/1991 | WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | US4992530 Treatment of calcium metabolic disorders, cardiac disease and ulcers |
| 02/12/1991 | US4992421 Suppression sex hormone in mammals |
| 02/12/1991 | US4992420 Dental anti-plaque and anti-caries agent |
| 02/12/1991 | US4992419 Freeze drying with buffer, urea, amino acids; storage stability, compatible |
| 02/12/1991 | US4992418 Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| 02/12/1991 | US4992417 Superactive human insulin analogues |
| 02/12/1991 | US4992369 Fermentation process for glycopeptide antibiotic |
| 02/12/1991 | US4992367 Genetic engineering |
| 02/12/1991 | US4992274 Tissue plasminogen activator A-chain/urokinase B-chain hybrid protein |
| 02/12/1991 | US4992273 Monoclonal antibodies secreted by hybridomas inhibits parasitic infections |
| 02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
| 02/12/1991 | CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | CA2022713A1 Human thrombomodulin derivatives |
| 02/12/1991 | CA2021880A1 Psycho-pharmacological peptides |
| 02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
| 02/11/1991 | CA2022608A1 Pharmaceutical compositions |
| 02/10/1991 | WO1991001996A1 Peptide fragments of hiv |
| 02/10/1991 | CA2064691A1 Peptide fragments of hiv |
| 02/10/1991 | CA2021059A1 Process for encapsulation of biologicals |
| 02/09/1991 | CA2022816A1 Compounds |
| 02/08/1991 | WO1991001758A1 Biologically active drug polymer derivatives |
| 02/08/1991 | CA2022685A1 Nitrosothiol derivatives, their production and use |
| 02/08/1991 | CA2022394A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 02/07/1991 | WO1991001393A1 Artificial biological membrane |
| 02/07/1991 | WO1991001380A1 Monoclonal antibodies directed against proteins involved in plaquettary functions, their applications as diagnostic and therapeutic agents |
| 02/07/1991 | WO1991001379A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 02/07/1991 | WO1991001378A1 Monoclonal antibodies directed against the proenzymes of b-like cathepsine and their biological applications |
| 02/07/1991 | WO1991001334A1 A purified, human autoregulatory cytokine, compositions containing same and uses thereof |
| 02/07/1991 | WO1991001327A1 Peptides containing diamino-glycols as transition-state mimics |
| 02/07/1991 | WO1991001144A1 Labeled polypeptide derivatives |
| 02/07/1991 | WO1991001143A1 Stable vaccine compositions containing interleukins |
| 02/07/1991 | WO1991001141A1 MODIFIED TRANSFORMING GROWTH FACTOR α OLIGOPEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/07/1991 | WO1991001138A1 Sequential heat treatment of blood-clotting factor products |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/07/1991 | WO1990015141A3 Self-assembled, defective, non-self-propagating viral particles |
| 02/07/1991 | WO1990015069A3 Amino acid derivative anticonvulsant |
| 02/07/1991 | DE3925183A1 Proteine mit tnf-wirkung Proteins with tnf-effective |
| 02/06/1991 | EP0412061A2 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same |
| 02/06/1991 | EP0412050A1 Novel cytokines |
| 02/06/1991 | EP0411946A2 DNA encoding human GP130 protein |
| 02/06/1991 | EP0411895A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411893A2 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/06/1991 | EP0411833A1 Fibrinogen receptor antagonists |
| 02/06/1991 | EP0411810A1 Factor VIII complex purification using heparin affinity chromatography |
| 02/06/1991 | EP0411770A1 Dental plaque degrading compositions |
| 02/06/1991 | EP0411751A1 Renin inhibitory peptides |
| 02/06/1991 | EP0411678A1 Method for the production of erythropoietin |
| 02/06/1991 | EP0411660A1 Antitumor antibiotic BU-4061T |
| 02/06/1991 | EP0411621A2 Electroresponsive hydrogel and physiologically active substance release control system |
| 02/06/1991 | EP0411334A1 Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain |
| 02/06/1991 | EP0411333A1 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain |
| 02/06/1991 | EP0411332A1 Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 02/06/1991 | EP0411096A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition |
| 02/06/1991 | EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 02/06/1991 | EP0410989A1 Cyclic analogs of atrial natriuretic peptides |
| 02/06/1991 | EP0215050B1 Purification of blood coagulation factor viii by precipitation |
| 02/06/1991 | EP0200748B1 Human tumor necrosis factor |
| 02/06/1991 | CN1049016A Peptidase inhibitors |
| 02/06/1991 | CA2022692A1 Renin inhibitors |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/05/1991 | US4990526 Skin disorders, antiallergens, antiinflammatory agents |
| 02/05/1991 | US4990455 Novel human TNF polypeptide mutants and DNA's encoding said mutants |
| 02/05/1991 | US4990448 Bu-4061T |
| 02/05/1991 | US4990337 Increased solubility and dispersibility |
| 02/05/1991 | US4990333 Treating with isolated omental lipid containing gangliosides |
| 02/05/1991 | CA2022609A1 Bu-4061t |
| 02/05/1991 | CA2022426A1 Electroresponsive hydrogel and physiologically active substance release control system |
| 02/05/1991 | CA1279950C Substituted dipeptide amides #2 |
| 02/05/1991 | CA1279823C Pharmaceutical and dietary composition for pre-menstrual syndrome |
| 02/03/1991 | WO1991002000A1 Il-2 deletion mutants |
| 02/03/1991 | CA2064696A1 Il-2 deletion mutants |
| 02/02/1991 | WO1991001719A1 Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes |
| 02/02/1991 | CA2038945A1 Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes |
| 02/01/1991 | CA2022273A1 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/01/1991 | CA2022111A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 01/30/1991 | WO1991001998A1 Proteins with tnf activity |
| 01/30/1991 | EP0410950A1 Immunosuppressive agents |
| 01/30/1991 | EP0410816A2 Detection of heparin binding seminal proteins |
| 01/30/1991 | EP0410767A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. |
| 01/30/1991 | EP0410713A1 Polypeptide inhibitor of viral replication |
| 01/30/1991 | EP0410671A1 Acylated epidermal growth factor |
| 01/30/1991 | EP0410541A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410540A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410539A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410537A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410411A2 Novel peptidase inhibitors |
| 01/30/1991 | EP0410372A1 Process for preparing human splenin derivatives |
| 01/30/1991 | EP0410278A1 Renin inhibiting aminooligohydroxy-derivatives |
| 01/30/1991 | EP0410260A2 Peptidyl aminodiol renin inhibitors |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410207A2 Stabilization of highly purified proteins |
| 01/30/1991 | EP0410178A1 CD4-fragment having anti-HIV activity |